Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Eric Wang, Ph.D., received his B.A. in Biochemistry from Harvard College and his Ph.D. from the Harvard-MIT Division of Health Sciences and Technology in Medical Engineering/Medical Physics with a focus on Bioinformatics and Integrative Genomics. He received an NIH Director’s Early Independence Award and launched his independent research group at the Koch Institute for Integrative Cancer Research at MIT. He is currently an Associate Professor in the Center for Neurogenetics and Department of Molecular Genetics and Microbiology at the University of Florida. His lab focuses on repeat expansion diseases, RNA biology, and development of therapeutic approaches. He has received grants from the Chan-Zuckerberg Initiative, Myotonic Dystrophy Foundation, Muscular Dystrophy Association, FARA, HDF, NIH, and DOD. He is also a co-founder of Kate Therapeutics, focused on gene therapies for muscle diseases.
